{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Phoenix&page=43&state=Arizona", "query": { "state": "Arizona", "city": "Phoenix", "page": 43 }, "page_size": 10 }, "pagination": { "page": 43, "page_size": 10, "total_count": 8145, "total_pages": 815, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Phoenix&page=44&state=Arizona&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Phoenix&page=42&state=Arizona&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-20T00:27:13.983Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02574455", "title": "Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Sacituzumab govitecan", "type": "DRUG" }, { "name": "Eribulin", "type": "DRUG" }, { "name": "Capecitabine", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Vinorelbine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 529, "start_date": "2017-11-07", "completion_date": "2020-12-08", "has_results": true, "last_update_posted_date": "2022-06-15", "last_synced_at": "2026-10-20T00:27:13.983Z", "location_count": 185, "location_summary": "Daphne, Alabama • Mobile, Alabama • Phoenix, Arizona + 144 more", "locations": [ { "city": "Daphne", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02574455" }, { "nct_id": "NCT00201643", "title": "A Randomized Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids (ACS) on Neonatal Outcome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Preterm Delivery" ], "interventions": [ { "name": "Betamethasone or Dexamethasone (2nd course of ACS)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Obstetrix Medical Group", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "FEMALE", "summary": "18 Years to 60 Years · Female only" }, "enrollment_count": 437, "start_date": "2003-11", "completion_date": "2008-02", "has_results": true, "last_update_posted_date": "2015-01-07", "last_synced_at": "2026-10-20T00:27:13.983Z", "location_count": 22, "location_summary": "Mesa, Arizona • Phoenix, Arizona • Tucson, Arizona + 16 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Laguna Hills", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00201643" }, { "nct_id": "NCT01256450", "title": "Efficacy and Safety Study of Buprenorphine HCl Buccal Film in Subjects With Low Back Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pain", "Low Back Pain" ], "interventions": [ { "name": "Buprenorphine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioDelivery Sciences International", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 334, "start_date": "2010-11", "completion_date": "2011-07", "has_results": true, "last_update_posted_date": "2017-02-27", "last_synced_at": "2026-10-20T00:27:13.983Z", "location_count": 24, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fresno", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01256450" }, { "nct_id": "NCT02167789", "title": "Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Heart Failure" ], "interventions": [ { "name": "Paradym CRT 8770", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "LivaNova", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 520, "start_date": "2009-09", "completion_date": "2013-06", "has_results": false, "last_update_posted_date": "2014-06-19", "last_synced_at": "2026-10-20T00:27:13.983Z", "location_count": 5, "location_summary": "Kaplan, Phoenix,, Arizona • Siegel, Phoenix,, Arizona • Boston, Massachusetts + 2 more", "locations": [ { "city": "Kaplan, Phoenix,", "state": "Arizona" }, { "city": "Siegel, Phoenix,", "state": "Arizona" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Montefiore, Bronx NY", "state": "New York" }, { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02167789" }, { "nct_id": "NCT07157774", "title": "Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Elevated Lp(a)", "Atherosclerotic Cardiovascular Disease (ASCVD)" ], "interventions": [ { "name": "Muvalaplin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10450, "start_date": "2025-09-02", "completion_date": "2031-03", "has_results": false, "last_update_posted_date": "2026-09-24", "last_synced_at": "2026-10-20T00:27:13.983Z", "location_count": 159, "location_summary": "Birmingham, Alabama • Apache Junction, Arizona • Gilbert, Arizona + 129 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Apache Junction", "state": "Arizona" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT07157774" }, { "nct_id": "NCT04939090", "title": "Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Advanced Malignant Solid Neoplasm", "Anorexia", "Hematopoietic and Lymphoid Cell Neoplasm" ], "interventions": [ { "name": "Olanzapine", "type": "DRUG" }, { "name": "Megestrol Acetate", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 227, "start_date": "2022-01-03", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-07-30", "last_synced_at": "2026-10-20T00:27:13.983Z", "location_count": 293, "location_summary": "Gilbert, Arizona • Goodyear, Arizona • Peoria, Arizona + 239 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Goodyear", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04939090" }, { "nct_id": "NCT04586010", "title": "A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Relapsing Multiple Sclerosis" ], "interventions": [ { "name": "Fenebrutinib", "type": "DRUG" }, { "name": "Teriflunomide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 746, "start_date": "2021-03-17", "completion_date": "2027-11-30", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-10-20T00:27:13.983Z", "location_count": 32, "location_summary": "Birmingham, Alabama • Homewood, Alabama • Phoenix, Arizona + 28 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Homewood", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Carlsbad", "state": "California" }, { "city": "Irvine", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04586010" }, { "nct_id": "NCT00314860", "title": "RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Restless Legs Syndrome", "Restless Legs Syndrome (RLS)" ], "interventions": [ { "name": "ropinirole Extended Release (XR)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "18 Years to 79 Years" }, "enrollment_count": 568, "start_date": "2006-02", "completion_date": "2006-12", "has_results": false, "last_update_posted_date": "2016-10-18", "last_synced_at": "2026-10-20T00:27:13.983Z", "location_count": 28, "location_summary": "Birmingham, Alabama • Mesa, Arizona • Phoenix, Arizona + 25 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00314860" }, { "nct_id": "NCT07359820", "title": "A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "FGFR2 Gene Fusion/Rearrangement", "Other Solid Tumors, Adult" ], "interventions": [ { "name": "Lirafugratinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Elevar Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2026-06-04", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2026-09-03", "last_synced_at": "2026-10-20T00:27:13.983Z", "location_count": 8, "location_summary": "Phoenix, Arizona • Jacksonville, Florida • Tampa, Florida + 5 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07359820" }, { "nct_id": "NCT01510158", "title": "Combining Lesinurad With Allopurinol in Inadequate Responders", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Gout" ], "interventions": [ { "name": "Lesinurad", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Allopurinol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ardea Biosciences, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 607, "start_date": "2012-01", "completion_date": "2014-08", "has_results": true, "last_update_posted_date": "2016-08-18", "last_synced_at": "2026-10-20T00:27:13.983Z", "location_count": 165, "location_summary": "Athens, Alabama • Birmingham, Alabama • Gulf Shores, Alabama + 139 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01510158" } ] }